Past Events

2022


  • January 13 – Dr. Gerhard Grüber, seminar: “Novel targets and -molecules derived from mechanistic and structural understanding of the mycobacterial F-ATP synthases”
  • February 9 – Dr. Jian Yu – seminar: “Intestinal Regeneration needs a ‘STING'”
  • March 8 – Dr. Binfeng Lu – seminar: “Tissue alarmin cytokines as a novel cancer immunotherapy”
  • March 17 – Dr. Jianxin Sun – seminar: “Regulation of Vascular Permeability by Latexin”

2021


  • January 13 – Dr. Lindsey James, seminar: “Promoting Illiteracy: Altering the H3 methylation landscape through inhibition of methyl-lysine readers”
  • January 27 – Dr. Jaewon Min, seminar: “Telomerase-independent telomere maintenance mechanisms in human cancers”
  • February 4 – Dr. Mone Zaidi, seminar: “Genes, Diseases and New Medicines – Lessons from Team Science”
  • February 10 – Dr. Khashayarsha Khazaie, seminar: “Regulatory T-cells in colorectal cancer”
  • February 18 – Dr. Fotini Gounari, seminar: “Co-operative signaling in double positive thymocyte development and transformation”
  • March 4 – Dr. Yi Zhang, seminar: “The Epigenetic Control of T Cell Stemness: A Guiding Role of EZH2”
  • March 17 – Dr. Michaela Reagan, seminar: “Investigating the Role of Fatty Acid Binding Proteins in Multiple Myeloma”
  • March 24 – Dr. Francesmary Modugno, seminar: “Of Mice and Women: New Directions in Ovarian Cancer Translational Research”
  • March 30 – Dr. Francesca Gany, seminar, “Multilevel Translational Research to Facilitate Health Equity”
  • April 8 – Dr. Robert Klein, seminar: “The role of inherited genetic variation in prostate cancer”
  • April 15 – Dr. Theresa Li-Yun Chang, seminar: “Not all type I IFNs are the same: IFN epsilon in immune response, viral infection and cancer.”
  • April 20 – Dr. Majid Kazemian, seminar: “Dissecting Host-pathogen interactions in infectious diseases: from cancer to COVID-19”
  • April 27 – Dr. Kelly O’Neill, Postdoc seminar: “Elucidating Molecular Heterogeneity Within theGlioblastoma Multiforme Tumor Microenvironment Using Matrix Assisted LaserDesorption/Ionization (MALDI) Mass Spectrometry Imaging (MSI)”
  • April 27 – Dr. Uday Ganapathy, Postdoc seminar: “A Leucyl-tRNA Synthetase Inhibitor withBroad-Spectrum Anti-Mycobacterial Activity”
  • May 12 – CDI | Georgetown – Postdoctoral Seminar Series Dr. Randi Williams: “Multilevel Approaches to Address Cancer Disparities in the Clinical Context” Dr. Shaymaa Bahnassy: ”Subclonal Hypermutation as a Potential Mechanism of Drug Resistance in HER2+/ER+ Breast Cancer”
  • May 20 – Dr. Ali Torkamani, seminar: “Genotype First”
  • June 1 – Dr. Patrizia Mondello, seminar: “Precision epigenetic-immunotherapy for B-cell lymphoma”
  • June 30 – Dr. Lok To (Chris) Sham, seminar: “Exploiting capsule synthesis pathway in Streptococcus pneumoniae to identify new antimicrobial compounds”
  • July 22 – Dr. Weiguo Cui, seminar: “T cell exhaustion in chronic viral infection and cancer”
  • August 11 – Dr. Jigarkumar Desai, seminar: “Complement C5a signaling in antifungal host defense”
  • August 18 – Dr. Alvin Makohon-Moore, seminar: “Evolutionary analyses of human cancers”
  • September 1 – Dr. Jayati Basu, seminar: “ThPOKing immune cell development and function”
  • September 22 – Dr. Kevin Tong, seminar: “SMAD4 in Colon Cancer: From Molecular Mechanisms to Modeling Cancer Progression”
  • October 6 – Dr. Ralph Francescone & Dr. Débora Barbosa Vendramini Costa – seminar: “Synaptic proteins promote microenvironmental support of pancreatic tumorigenesis”
  • October 21 – Dr. Robert Bowman – seminar: “Uncovering the basis of oncogene-dependency and subclonal evolution in hematopoietic transformation”
  • November 4 – Dr. Jacqueline Achkar – seminar: “Antibody-mediated immunity against TB: What have we learned so far”
  • November 8 – Dr. Lin Zhang, seminar: “Immunogenic Cell Death in Colorectal Cancer Therapy and Prevention”
  • November 16 – Dr. Manpreet Bariana, Postdoc seminar: “Targeting NF-κB in multiple myeloma with a small molecule inhibitor”
  • November 16 – Dr. Jickky Sarathy, Ph.D., Postdoc seminar: “Targeted protein degradation in mycobacteria”
  • December 8 – Dr. Tiago Alfredo Rodrigues Beites – seminar: “Sabotaging Mycobacterium tuberculosis nutritional adaptation to the host”

2020


  • January 13 – Chen Zhao, seminar: “NF- B/Notch Signaling in B cell transformation and Plasticity”
  • January 24 – Dr. Masood Kamali-Moghaddam, seminar: “Molecular Tools for Parallel Detection and Characterization of Proteins and Exosome”
  • January 27 – Virginia Pascual, seminar: “New Insights into Pediatric Lupus Pathogenesis”
  • February 5 – Dr. Scott Evans, seminar: “Developments in Oncology Clinical Trials”
  • March 3 – Dr. Jyothi Nagajyothi, seminar: “Adipose tissue, Adipocytes, and Adipomes- the regulators of TB pathology”
  • March 4 – Dr. Stephen Sykes, seminar: “Regulation of Serine Synthesis & Catabolism in Acute Myeloid Leukemia”
  • March 9 – Dr. Mary Beth Terry, Genomic Medicine Series seminar: “Improving Cancer Risk Stratification and Risk Reduction”
  • May 13 – Dr. Katrin D. Mayer-Barber, seminar: “Granulocytic Immune responses to Mtb – Eosinophils kick it off!”
  • May 22 – Dr. Sharon Manne, seminar: “Cancer Survivorship: State of the Science, Models of Care, and Interventions to Improve Self-Management”
  • June 17 – Dr. Mark Bustoros, seminar: “Advancements in precursor states of Plasma cell Dycrasias”
  • July 7 – Dr. Brendon Lee, seminar: “Predicting antibiotic resistance mutations in Mycobacterium tuberculosis using protein engineering”
  • July 14 – Dr. Leandro Cerchietti, seminar: “Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures”
  • July 17 – Dr. Wendy Chung, Genomic Medicine Series seminar: “Opportunities in Genomic Medicine”
  • July 20 – Dr. Grant Challen, seminar: “The Epigenetic Regulation of Hematopoietic Stem Cells – From Clonal Hematopoiesis to Blood Cancers”
  • July 22 – Dr. Minh Hong Thi Nguyen, seminar: “Opportunistic infections complicating viral infections”
  • July 29 – Dr. Jonathan Yewdell – seminar: “Antibody Immunodominance to Viruses”
  • September 22 – Dr. Francesca Ferraro, seminar: “Immune evasion mechanisms by de novo Acute Myeloid Leukemia Cells”
  • October 7 – Dr. Warren J. Leonard, seminar – “The γc family of cytokines and fine-tuning their signals”
  • October 15 – Dr. Jason Sheltzer, seminar: “The role of aneuploidy in cancer development”
  • October 27 – Dr. Megan Mitchell, Postdoctoral seminar, “Optimization of a versatile, high-purity exosome purification assay for biomarker discovery”
    Dr. Dereje Negatu, Postdoctoral seminar, “Human gut microbiota metabolite targets amino acid biosynthesis in Mycobacterium tuberculosis”
  • November 3 – Alexandre Cheng, Ph.D. student, seminar: “Liquid biopsies for infectious and immune diseases”
  • November 11 – Dr. Nagi G. Ayad, Seminar: “Multi-omics approaches for identifying synergistic combinations in brain cancer”
  • November 19 – Dr. David van Duin, Seminar: “Infections in immunocompromised hosts: challenges and opportunities”
  • April 27 – Dr. Kelly O’Neill, Postdoc seminar: “Elucidating Molecular Heterogeneity Within the Glioblastoma Multiforme Tumor Microenvironment Using Matrix Assisted LaserDesorption/Ionization (MALDI) Mass Spectrometry Imaging (MSI)”
  • November 24 – Dr. Meenal Datta, Seminar: “Abnormal Mechanics in Brain Tumors: Implications for Immunotherapy”
  • December 10 – Dr. Michail Lionakis, seminar: “Of mice and humans: Host defense against fungal disease”